Monoclonal antibodies recognizing CD18, CD1la, CD1lb, and neutrophil lectin adhesion molecule 1 (LECAM-1), i.e., the human homologue of the murine MEL-14 antigen, were used to assess the relative contribution of these glycoproteins to neutrophil-endothelial adhesion. Under static conditions, the adhesion of neutrophils to IL-l-stimulated human umbilical vein endothelial cell (HUVEC) monolayers was inhibited by antibodies to CD18, CD1 la, and the neutrophil LECAM-1, and the effect of combining anti-LECAM-1 and anti-CD1 la was almost additive. Under flow at a wall shear stress of 1.85 dyn/ cm2, a condition where CD18-dependent adhesion is minimal, anti-LECAM-1 inhibited adhesion by > 50%. Chemotactic stimulation of neutrophils induced a rapid loss of LECAM-1 from the neutrophil surface, and the level of neutrophil surface LECAM-1 was closely correlated with adhesion under flow. Neutrophils contacting the activated endothelial cells for 30 min lost much of their surface LECAM-1, a phenomenon induced by a soluble factor or factors released into the medium by the stimulated monolayers, and a high percentage migrated through the HUVEC monolayer. This migration was almost completely inhibited by anti-CD18, but was unaffected by antibodies to neutrophil LECAM-1. These results support the concept that LECAM-1 is a neutrophil adhesion molecule that participates in the adherence of unstimulated neutrophils to cytokine-stimulated endothelial cells under conditions of flow, and is then lost from the neutrophil surface coincident with the engagement of CD18-dependent mechanisms leading to transendothelial migration. (J. Clin. Invest. 1991. 87:609-618.) 
Introduction
The adherence of human neutrophils to human endothelial cells under static conditions in vitro is increased by chemotactic stimulation of the neutrophils (1-10), or by stimulation of the endothelial cells with endotoxin or cytokines, e.g., IL-I 3 (4, [6] [7] [8] [9] [11] [12] [13] [14] [15] . Studies using monoclonal antibodies indicate that the adherence of stimulated neutrophils is dependent on both CD1 la/CD18 (LFA-1) and CDl lb/CD18 (Mac-i) (4, 5, 7, 9, 10) , but the adherence of unstimulated neutrophils to stimulated endothelial cells appears to be more complex. It depends on endothelial intercellular adhesion molecule 1 (ICAM-1)' interacting with CD1 la/CD 18 (LFA-1) on the neutrophil (6) , and endothelial-leukocyte adhesion molecule 1 (ELAM-1) (16, 17) interacting with an unknown, CD 18-independent structure on the neutrophil (18) . Recently, evidence was obtained that the human homologue ofthe murine antigen (19, 20) on the neutrophil, identified by (21) , Leu8 , and TQ1 (22, 23) or anti-LAM-i (23) , is also involved and interacts with an unknown structure on the endothelial cell (23a). The roles these various molecules play in the neutrophil functions enhanced by or requiring adhesion are poorly de- fined. While evidence exists that Mac-1 is involved in adherence-dependent H202 production (24, 25) , and LFA-1, Mac-1, and ICAM-1 are necessary for optimum transendothelial migration (7, 9) , the functional contributions (other than adhesion) of ELAM-I and the MEL-14 antigen, both members of the lectin-cellular adhesion molecule (LEC-CAM) family of adhesion molecules (26) , are unknown.
Monoclonal antibody and MAbs to LFA-I and Mac-I markedly reduce mouse neutrophil extravasation to inflamed tissues in vivo (27, 28) . We have observed that chemotactic stimulation causes a rapid shedding of the LEC-CAM from the surface ofmurine neutrophils (29) and human neutrophils (30) . This rapid down-regulation occurs coordinately with rapid upregulation of Mac-I expression and function, which effectively turns off one adhesion mechanism while turning on another mechanism. The loss of neutrophil LEC-CAM and the increase in Mac-I is observed not only in vitro, but also in vivo in neutrophils in the process ofextravasating in inflammatory sites (28, 29) . These results suggest that Mac-I and LEC-CAM on the neutrophil surface mediate fundamentally distinct adhesion events. We have proposed that neutrophil lectin adhesion molecule 1 (LECAM-1) is critical for the initial binding event between unstimulated neutrophils in circulation and the inflamed endothelium, whereas LFA-I and Mac-I may be more important for adhesion strengthening and transendothelial migration. In this article we directly test this hypothesis in an in vitro model examining adhesion under shear stress, transendothelial migration, and neutrophil activation. Since a MAb (DREG-56) to human LECAM-1 that blocks the lectin activity of this molecule on human neutrophils and lymphocytes (30) has recently been developed (21) , these studies were performed using human cells.
Methods
Isolation ofpolymorphonuclear leukocytes. Neutrophils were obtained from healthy adult individuals and three patients with the severe phenotype ofCD 18 deficiency (31) were purified from citrate anticoagulated, dextran-sedimented venous blood samples over Ficoll-Hypaque gradients and were suspended in Dulbecco's phosphate-buffered saline (PBS; Gibco Laboratories, Grand Island, NY), pH 7.4, containing 0.2% dextrose as described (7) . Neutrophils were maintained at 40C in PBS for up to 4 h at a concentration of 107/ml.
Monoclonal antibodies. MAbs used in these studies included preparations of IgG, and F(ab')2 fragments. The anti-CD 18 MAb, R1 5.7 (IgGl) (32) and anti-CDI la MAb, R3.1 (IgGi) (7) were prepared as previously described. Anti-CD1 spectively. One anti-neutrophil MAb 4A5 (IgG 1) was prepared as previously described (7), and used as a control in the adherence and migration assays. It has been evaluated in our laboratory for the ability to inhibit neutrophil adherence to endothelial cells, and found to be without effect. A MAb to the human homologue of the MEL-14 antigen, DREG-56 (IgG 1) was prepared as previously described (21) , and another MAb with this specificity, Leu8 tagged with FITC, was purchased from Becton, Dickinson & Co. All MAbs that bind to neutrophils were titered using flow cytometry (FACScan, Becton, Dickinson & Co.) to determine the concentration that saturated surface binding sites of unstimulated and stimulated cells (i.e., stimulation with 10 nM FMLP, 370C, 15 min). In most functional studies, MAbs were initially used at twice the saturating concentration.
Immunofluorescenceflow cytometry. The quantitation of MAb binding to neutrophils involved the use of fluorescein isothiocyanate (FITC)-or PE-tagged antibodies. In some instances, the fluorochrome was directly attached to the primary antibody, in others it was attached to a F(ab')2 goat anti-mouse second antibody for indirect detection of the primary antibody binding. Analysis was performed on a FACScan, and results were expressed as mean relative linear fluorescence.
Studies designed to assess the kinetics of change in the surface antigen recognized by a specific antibody after chemotactic stimulation of the neutrophils were performed in two ways. In one protocol, neutrophils were suspended in 0.1 ml PBS and exposed at 37°C to the stimulus (e.g., 10 nM FMLP). At the specified time, the cell suspension was diluted IOX in ice-cold PBS and maintained at ice bath temperatures during the subsequent preparation of the cells for flow cytometry, i.e., tagging with the appropriate primary and secondary antibodies, and fixation in 5% paraformaldehyde as previously described (7) . In some cases, a second protocol was used to assess the changes occurring within the first few minutes after stimulation: neutrophils were suspended for 10 min at 37°C in PBS containing the primary antibody (directly labeled with the fluorochrome) at saturating concentrations. This preparation was then directly sampled in the flow cytometer to determine the baseline level of fluorescence of these viable cells. Preparation of human umbilical vein endothelial cells (HUVEC). The cells were harvested and characterized as to acetylated low-density lipoprotein (acLDL) binding and factor VIII expression according to established techniques as previously described (7) . Cells from 5-10 umbilical cords were pooled and plated in RPMI 1640 containing 10% fetal calf serum (FCS) and 10% bovine serum, antibiotics, heparin (0.1 mg/ml), and endothelial cell growth factor (0.05 mg/ml), and maintained for 3-4 d at 370C, 5% CO2 humidified atmosphere. Visually confluent monolayers on gelatin (0.1%) coated 25-mm round or 24 50-mm rectangular glass coverslips were prepared from first passage cells harvested with 0.05% trypsin and 0.02% EDTA in PBS. HUVEC were pretreated with various concentrations of interleukin 1 (IL-1; Genzyme, Boston, MA), in most instances for 3-4 h, a time previously shown to be optimal for the enhancement of neutrophil adherence (6) .
HUVEC-conditioned supernatants were prepared from HUVEC monolayers that were either unstimulated or stimulated with IL-I for up to 5 h. The monolayers were rinsed by dipping five times in two changes of PBS and then overlaid with 0.3 ml of PBS for 1 h at 370C. The supernatant was collected, centrifuged at 10,000 g for 5 min to remove any detached cells and debris, and used immediately as a potential stimulus for isolated, previously unstimulated neutrophils.
Adherence assay under static conditions. A visual adherence assay was utilized as previously described (6) . It should be noted that the procedure used in this study does not utilize shear stress as with techniques requiring a washing step (4, 5, 10, (35) (36) (37) . HUVEC monolayers on 25-mm round glass coverslips were washed by dipping three times in two changes of PBS and immediately inserted into the adherence chambers specifically made for use with an inverted microscope and phase-contrast optics. The chambers consisted of two metal plates designed to hold two 25-mm round cover glasses separated by a SykesMoore chamber O-ring (Bellco Glass Inc., Vineland, NJ). Within this closed compartment neutrophils could be observed as they contacted the HUVEC monolayer. Neutrophils suspended in PBS (106 cells/ml) were injected into the chamber and allowed to settle onto the monolayer for a period of 500 s. The number of neutrophils in contact with the monolayer was determined by counting at least 10 microscopic fields (SOX objective), and the chamber inverted for an additional 500 s. The percentage of cells remaining in contact with the monolayer was determined and is expressed in the Results as percent adherence. The percentage of cells migrating through the endothelial monolayer was also determined using previously described criteria (6, 7) . In blocking experiments, neutrophils were pretreated for 5 min; then the cell suspension was injected into the adherence chamber without washing.
This adhesion assay was carried out at room temperature, and the migration assay was carried out at 37°C to increase the percentage of migrating cells. Chemotactic stimulation of neutrophils prior to assessing adhesiveness was performed in the following manner: Neutrophils suspended in PBS (I07 cells/ml) were exposed to 10 nM FMLP for 30 min at 37°C, then diluted to 106/ml in PBS immediately before being injected into the adhesion chamber.
Adherence assay under conditions offlow. A modification of a previously published procedure (8, 15) was used. Passage one HUVEC were grown to confluence on fibronectin-coated coverslips (Bellco Glass, Inc.), stimulated with IL-1 (5 U/ml) for 3-4 h, rinsed in serumfree medium (RPMI 1640) and mounted in parallel plate flow chambers. Neutrophils were suspended in culture medium (RPMI 1640) without serum, and treated as described in the text for each specific experiment. The neutrophil suspensions were passed through the chamber at a wall shear stress of0.36 or 1.85 dyn/cm2, and the interaction of neutrophils with the endothelial monolayer was observed under phase-contrast microscopy (Diaphot-TMD, Nikon, Inc., Garden City, NY) for 10 min and recorded on video tape. Digitized frames (Perspective System, Inc., Houston, TX) from videotaped experiments were used to determine the number of neutrophils that remained in contact with the monolayer. Transendothelial migration was evaluated as previously described (8) 
Results
Chemotactic stimulation inversely regulates thefunctionalactivity of CDJJ/CD18 and neutrophil LECAM-J. As shown previously (30) , antibodies recognizing CD1 8 and neutrophil LECAM-1 bound to most neutrophils. The loss of binding of Leu8 and increased binding ofR 15.7 after chemotactic stimulation for 30 min at 370C involves most of the neutrophils (Fig.  1) . In an effort to assess the rate at which the LEC-CAM was lost from the neutrophil surface after stimulation, viable neutrophils were directly sampled for flow cytometry at 1-min intervals after addition of 10 nM FMLP (Fig. 2) . A significant rise in Leu8 binding was seen at 1 min after stimulation followed by a significant drop in binding that was evident at 3 min and almost complete by 10 min. Unstimulated cells failed to show either a rise or fall in Leu8 binding over this observation period (data not shown). As shown in duce the binding of DREG-56 to the neutrophil significantly reduced the adhesion of neutrophils exposed to R15.7. These data also indicate that FMLP stimulation and its associated loss of the surface antigen recognized by Leu8 and DREG-56 reduced adhesion of CDl 8-blocked cells to a greater degree than DREG-56. Previous studies have shown that CD18-deficient neutrophils adhere to IL-l stimulated HUVEC monolayers at -50% the level of normal neutrophils (7). Consistent with our previous studies (23a), DREG-56 reduced adhesion of CD18-deficient neutrophils by 38.4±5% (n = 3, P < 0.01), and additionally, preincubation for 30 min at 37°C in 10 nM FMLP (thereby reducing DREG-56 binding from a mean fluorescent channel of 105±17 to 12±3) reduced adhesion by 65.4±4% (P < 0.01, n = 3).
The basal level of adherence of normal neutrophils to unstimulated HUVEC (14.7±1.6%, n = 3) was not significantly influenced by incubation with 50 ug/ml DREG-56 (17.8±1.8%, n = 3), but was significantly reduced in the presence of 5 Ag/ml R15.7 (3.1±2.0%, n = 3, P < 0.01). These results indicate that the endothelial structure with which neu- Additional experiments were performed to assess the requirement for neutrophil LECAM-1 in adhesion under conditions of flow. As shown in Fig. 6 , neutrophils stimulated with various concentrations of FMLP exhibited partial reductions in surface LECAM-1 commensurate with the level of stimulation, and adhesion at 1.85 dyn/cm2 was highly correlated with the neutrophil surface level of LECAM- 1. Stimulated endothelial cells induce down-regulation ofneutrophil LECAM-J. Kishimoto et al. (29) presented the hypothesis that in the mouse, the MEL-14 antigen is responsible for the initial adhesive interactions between neutrophils and endothelial cells, with subsequent involvement of CD 18-dependent adhesion as neutrophils are activated in situ and migrate through the endothelium. Detachment of the adhesive mechanism dependent on neutrophil LECAM-1 is an essential event in this scheme. From the results presented above, it appears that LECAM-1 may play such a carefully coordinated role in human neutrophil-endothelial adhesion. In order to assess whether detachment of this adhesive mechanism occurs, the following experiments were performed.
Using the static adhesion assay at 37°C, previously unstimulated neutrophils were allowed to contact IL-1-stimulated (3 U/ml, 3 h, 37°C) endothelial monolayers for 500 s. The monolayers were inverted for an additional 500 s, and the percent adherent cells determined. In order to prevent CD1 8-dependent migration ( In order to compare the effect of neutrophil contact with unstimulated and IL-1 stimulated endothelial cells, neutrophils were allowed to remain on HUVEC monolayers for 30 min or 1 h at 37°C, collected by rinsing the monolayers with PBS, and evaluated for binding of FITC labeled Leu8. Both R 15.7-treated normal neutrophils and CDl 8-deficient neutrophils on unstimulated HUVEC exhibited the same level of binding as controls, i.e., cells not in contact with the monolayers and maintained at 4°C in PBS or incubated at 37°C with IL-1 in PBS. In contrast, neutrophils on IL-1-stimulated HU-VEC had greatly reduced binding of Leu8 (Fig. 8) .
The possibility that a soluble factor was released from stimulated HUVEC monolayers was evaluated by collecting supernatants from both unstimulated and stimulated monolayers. Neutrophils were exposed to these supernatants and evaluated for the ability to bind DREG-56. Supernatants from unstimulated HUVEC monolayers were without effect, while those from IL-1-stimulated HUVEC produced marked reductions in the neutrophil's ability to bind DREG-56 (Fig. 9) , and to adhere to IL-i-stimulated HUVEC monolayers (Table I) Fig. 11 , both can induce the coincident up-regulation of Mac-i, and loss of LECAM-l from the neutrophil surface.
Anti-CD18 but not DREG-56 blocks neutrophil transendothelial migration. IL-1-stimulated HUVEC promote transendothelial migration of previously unstimulated normal neutrophils (6, 41, 42 ). This appears to be largely a CDl 8-dependent process since anti-CD 18 MAbs produce > 90% inhibition, and CD1 8-deficient neutrophils exhibit < 3% ofthe migration of normal cells (6) . The possibility that the antigen recognized by DREG-56 also plays a role in this migration was investigated by quantitating migration in the presence of this MAb. In the assay performed without shear stress, a concentration of DREG-56 sufficient to produce maximum reduction in adhesion (50 ,g/ml) did not reduce the number of migrating neutrophils (Fig. 12) , while in parallel studies, RI 5.7 almost completely inhibited migration, 904 (anti-CD1 lb) produced Pretreatment:
Neutrophils per mm2 ies against CD 18 that markedly inhibit adhesion to IL-I -stimulated HUVEC under static conditions, are ineffective in reducing adhesion at wall shear stresses in this range in vitro (8, 9) . In contrast, DREG-56 is more effective in reducing adhesion under these flow conditions than under static conditions, indicating that LECAM-I on the surface of neutrophils may play a significant role in neutrophil-endothelial adherence under conditions where leukocyte integrins are ineffective. This concept is supported by three additional observations. The first is that neutrophils from patients with CD18 deficiency exhibit high levels of adhesion to IL-I-stimulated HUVEC at wall shear stresses -2.0 dyn/cm2 (8, 9) . The second is that chemotactic stimulation of normal and CD 18-deficient neutrophils under conditions shown to markedly reduce LECAM-I on their surface reduces adhesion under flow to same degree as DREG-56, and combination of chemotactic pretreatment and DREG-56 produces no further reduction in adherence. The third is that the level of LECAM-1 on the neutrophil surface is directly related to the capacity to adhere to IL-1-stimulated HUVEC under conditions of flow.
Chemotactic stimulation of normal neutrophils increases their adhesion to endothelial cells under static conditions ( 1-4, 7, 10) or flow with very low wall shear stresses (0.25 dyn/cm2) in vitro (8, 9) . This effect appears to be primarily dependent on Mac-i (4, 5, 7, 10), as shown by the fact that MAbs against CD1 lb and CD18 reduce adhesion to near unstimulated levels. The observation that chemotactic stimulation removes the majority of LECAM-1 from the neutrophil surface seems to preclude a role for LECAM-1 in the adhesion of chemotactically stimulated neutrophils, a conclusion supported by the results of two experiments. Adhesion of CDl 8-deficient neutrophils to IL-1-stimulated HUVEC under static conditions was signifipartial inhibition, and a control MAb (4A5) that binds to neutrophils without inhibiting adhesion (7) failed to influence migration. In the assay performed under flow, the proportion of adherent neutrophils that migrated beneath the monolayer in the presence of DREG-56 (70.6±8.1%, n = 10) was the same as in the absence of MAbs (68.6±8.9%, n = 16). However, the total number of migrated cells per square millimeter was reduced by DREG-56 since this antibody significantly reduced the number of neutrophils adhering to the endothelium and thereby the number of cells available to migrate (migrated cells per square millimeter without MAbs, 697±171, n = 16; with DREG-56, 354±77, n = 10, P < 0.01).
Discussion
The current studies demonstrate that CD1 8 integrins, Macand LFA-1, and LECAM-1 on the human neutrophil surface play distinct roles in the adhesion ofthese leukocytes to human endothelial cells in vitro. The distinctions can be clearly identified in three areas: (a) neutrophil-endothelial adhesion under conditions of flow, (b) adhesion after chemotactic stimulation lation of the neutrophils, and (c) transendothelial migration induced by cytokine stimulation of the endothelial cells.
Human neutrophils will adhere to IL-l-stimulated HU-VEC monolayers in vitro in parallel plate flow chambers at a wall shear stress of -2.0 dyn/cm2 (15) . Monoclonal antibod- Figure 7 . Detachment of neutrophils from IL-I-stimulated HUVEC monolayers. HUVEC monolayers were stimulated for 3 h with IL-1, rinsed in PBS, and inserted into adherence chambers. Control neutrophils were suspended in PBS containing 10 Og/ml R15.7, and CDl 8-deficient neutrophils were suspended in PBS before being injected into the chamber. Neutrophils were allowed to settle onto the monolayer for 500 s, the chamber was inverted for 500 s, and the percentage of adherent cells was determined immediately and at 20 and 30 min. Number of separate experiments, six using normal cells, and three using CD1 8-deficient cells. A striking feature of cytokine-stimulated HUVEC monolayers is that they induce transendothelial migration of adherent human neutrophils (6, 41, 42) . Though the endothelial factor(s) responsible for stimulating this neutrophil motility have not been defined, the adhesion molecules on the neutrophil involved in this event appear to be primarily leukocyte integrins, specifically Mac-and LFA-1 (7, 9) . This conclusion is supported by the following findings: (a) MAbs against the a subunits of these integrins are capable of decreasing migration by up to 50% when used alone and by greater that 90% when added together; (b) transendothelial migration of CD1 8-deficient cells is very infrequent; and (c) DREG-56 does not inhibit migration of adherent normal neutrophils. This conclusion is also reasonable in light of the observation that chemotactic stimulation induces a loss of LECAM-1 from the neutrophil surface. If the endothelial-dependent leukocyte migration results from chemotactic factors produced by the monolayer, such stimulation would likely result in the loss of LECAM-1. Results in this report directly show that endothelial derived factors stimulate a rapid loss of LECAM-I from the neutrophil, and recent studies show that neutrophil migration through HUVEC monolayers toward chemotactic gradients is almost completely inhibited by anti-CD 1 8 MAbs and unaffected by neutrophil adhesion to endothelial cells under inflammatory conditions involves at least two distinct sets ofadhesive mechanisms. One involves LECAM-1 on the neutrophil surface, and the second involves leukocyte integrins. Two key features of this hypothesis are first, that these mechanisms act sequentially in vivo, the LECAM-1 mechanism being responsible, at least in part, for the initial adhesion, and leukocyte integrins being responsible for continued adhesion and subsequent emigration, and second, that the initial mechanism is "down-regulated" as the second mechanism is engaged, presumably by chemotactic factors in the inflammatory site. Additional evidence supporting this hypothesis and its application to human cells comes from the results in this and a separate report (23a). Two experiments have direct bearing on the first point. As discussed above, neutrophils flowing by an IL-1-stimulated HUVEC monolayer can adhere by a mechanism dependent on the neutrophil surface LECAM-1, and transendothelial migration is primarily a CD I 8-dependent event. Two experiments have direct bearing on the second feature. CDl 8-deficient neutrophils in contact with IL-1-stimulated, but not unstimulated HU-VEC monolayers exhibited a rapid loss of ability to bind DREG-56 or Leu8, and coincident detachment from the monolayer. Detachment and loss of LECAM-1 were demonstrated with normal neutrophils when CD1 8-dependent adhesion and migration were blocked by addition of anti-CD 1 8 MAb, thus allowing recovery of the cells in contact with HUVEC. The time course of this event was similar to that when chemotactic factor was added to cells in suspension. Supernatant from IL-1-stimulated, but not unstimulated HUVEC monolayers induced a rapid loss of LECAM-1 from the neutrophil surface associated with a significantly reduced ability to adhere to stimulated endothelial cells. These observations provide direct evidence for the sequential operation of these distinct adhesive mechanisms.
The identity of the endothelial surface determinant interacting with neutrophil LECAM-I is unknown. Since the adhe- and high levels of surface Mac-I when compared with neutrophils from blood or bone marrow. Kishimoto et al. (29) found that neutrophils within the lumen of blood vessels exhibited bright immunofluorescent staining for MEL-14 antigen, whereas those that had migrated into the tissues at a site of inflammation exhibited no immunofluorescent staining for MEL- 14 antigen, but stained brightly for Mac-1. Thus, studies both in vitro and in vivo reveal neutrophil LECAM-I to be an adhesion molecule functional at venous wall shear stresses, and studies in vitro indicate that the marked changes seen in surface adhesion molecules on exudate neutrophils may be due in part to factors released from inflamed endothelium.
